Skip to main content
. 2009 Nov 9;27(36):6117–6123. doi: 10.1200/JCO.2008.20.2952

Fig 1.

Fig 1.

(A-C) Schemas of all three trials. Black arrows indicate timing of LVEF (left ventricular ejection fraction) measurement reported in this analysis. q2w, every 2 weeks; qw, weekly; q3w, every 3 weeks; MUGA, multigated radionuclide angiography. (*) Pegfilgrastim was given subcutaneously on day 2 after chemotherapy.